Atlas Trials

Hyundai Pharm

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Hyundai Pharm

RecordFirmDate
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia (NCT06646354)Hyundai Pharm2025-04-22
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise (NCT06647550)Hyundai Pharm2024-12-12
To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults (NCT06578676)Hyundai Pharm2024-06-20
Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults (NCT05804279)Hyundai Pharm2022-12-28
Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise (NCT05666128)Hyundai Pharm2022-06-17
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects (NCT05677035)Hyundai Pharm2022-01-11

Track Hyundai Pharm automatically

Every clearance here is in the API, with alerts when new ones post.